Trials / Unknown
UnknownNCT01293474
Choroidal Thickness in Glaucoma Patients and Healthy Controls
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
With the new software tool (EDI, enhanced depth imaging) of the Spectralis® spectral-domain optical coherence tomography (SD-OCT) it is possible to visualize and measure the choroidal thickness. In glaucoma a vascular component is known. Therefore a difference of choroidal thickness in glaucoma patients and healthy controls is proposed. * Trial with medical device
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Spectralis® SD-OCT, Heidelberg Engineering GmbH, H | Measurement of the choroidal thickness with Spectralis® SD-OCT |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2011-02-10
- Last updated
- 2015-01-06
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01293474. Inclusion in this directory is not an endorsement.